No abstract available
MeSH terms
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Cell Division / physiology
-
Hamartoma / enzymology
-
Hamartoma Syndrome, Multiple / enzymology
-
Humans
-
Melanoma / drug therapy
-
Melanoma / enzymology
-
Melanoma / secondary
-
Molecular Targeted Therapy
-
PTEN Phosphohydrolase / genetics
-
PTEN Phosphohydrolase / physiology
-
Phosphatidylinositol 3-Kinases / genetics
-
Phosphatidylinositol 3-Kinases / physiology*
-
Protein Kinase Inhibitors / therapeutic use
-
Proteus Syndrome / enzymology
-
Proto-Oncogene Proteins c-akt / physiology
-
Signal Transduction / drug effects
-
Signal Transduction / genetics
-
Signal Transduction / physiology*
-
Skin Diseases / classification
-
Skin Diseases / drug therapy
-
Skin Diseases / enzymology*
-
Skin Diseases / genetics
-
Skin Diseases / pathology
-
Syndrome
-
TOR Serine-Threonine Kinases / physiology
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
MTOR protein, human
-
PIK3C2A protein, human
-
AKT1 protein, human
-
Proto-Oncogene Proteins c-akt
-
TOR Serine-Threonine Kinases
-
PTEN Phosphohydrolase
-
PTEN protein, human